The CDC gave ASCA an overview of the process behind various recommendations, including their position on single-dose/single-use vials. The CDC also discussed past and recent outbreaks of infectious diseases associated with unsafe injection practices.
The ASCA representatives raised concerns that recommendations may not be based in scientific evidence, and asked for clarification from the agency as to why a more nuanced process pertaining to single-use vials could not be developed. ASCA suggested the improved process would protect patients while eliminating drug waste that costs the industry money.
ASCA also briefed the agency on different injectable drugs that ASCA members were either having trouble obtaining at all or having trouble obtaining in appropriate doses.
Learn more about ASCA.
Related Articles on Anesthesia:
Anesthesiologist Dr. Sue Carlisle Named Vice Dean of UCSF School of Medicine
Pediatric Anesthesiologist Dr. Andrea Dutoit Joins OU Children’s Physicians
Anesthesiologist Dr. David G. Nichols Named President of American Board of Pediatrics
